Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Oceanpine Capital: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Oceanpine Capital
Oceanpine Capital
Active
Website
LinkedIn
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 1, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Oceanpine Capital.
DC
Dave Chenn
Chief executive officer
SH
Shirley Hu
Managing Director
AS
Adam Sun
Managing Partner
DM
Dongjun Ma
Managing Partner
Leadership Team
Key people at Oceanpine Capital.
Dave Chenn
Chief executive officer
SH
Shirley Hu
Managing Director
Adam Sun
Managing Partner
DM
Dongjun Ma
Managing Partner
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Jan 1, 2024
Orange Dental
$130.0M Series B
Oceanpine Capital
,
OrbiMed
3W Capital
,
Adjuvant Capital
,
AIHC Capital
,
Eight Roads Ventures
, F-Prime Capital
,
Haitong International
,
Hillhouse Capital Group
,
MSA Capital
,
Superstring Capital
Aug 1, 2021
SVOLT
$1.6B Series B
Bank of China Group Investment
CCB International
,
China Renaissance
,
Country Garden Venture Capital
, Guotou Chuangye
,
IDG Capital
,
JZ Capital
,
Shenzhen Capital Group
,
Sub-funds of National Fund for Technology Transfer and Commercialization
,
Xiaomi
Apr 26, 2021
Hepagene Therapeutics
$40.0M Series B
Loyal Valley Capital
Apricot Capital
Mar 30, 2021
Immune-Onc Therapeutics
$73.0M Onc Therapeutics - Series B
Dave Chenn
Northern Light Venture Capital
,
Octagon Capital
,
Sphera Healthcare
,
The Leukemia & Lymphoma Society
,
Vivo Capital
Feb 23, 2021
Teon Therapeutics
$30.0M Series A
Dave Chenn
Kaitai Capital
,
Lifespan Investments
, Feng Deng
,
Oriza Ventures
Feb 1, 2021
LakeShore Biopharma
$130.0M Series B
OrbiMed
, Dave Chenn
3W Capital
,
Adjuvant Capital
,
AIHC Capital
,
Eight Roads Ventures
,
Epiphron Capital
, F-Prime Capital
,
Haitong International
, Hillhouse Capital
,
MSA Capital
,
Superstring Capital
Sep 27, 2020
Creative Biosciences
$87.9M Series C
—
CDH Investments
,
IDG Capital
,
Shengyu Investment
Aug 13, 2020
hireEZ
$13.0M Series B
Dave Chenn
—
Aug 1, 2020
Triumvira Immunologics
$55.0M Series A
Northpond Ventures
, Juergen Eckhardt
Brian Bloom
,
Centre for Commercialization of Cancer Immunotherapy
Mar 24, 2020
Apexigen
$65.0M Series C Extension
Decheng Capital
,
Oceanpine Capital
—
Oct 15, 2019
Ansun BioPharma
$7.9M Series B
Junson Capital
,
Korea Investment Partners
,
Oceanpine Capital
—
Oct 9, 2018
Rgenix
$40.0M Series C
Zhongjie Pu
Alexandria Venture Investments
, Novo Holdings
,
Partnership Fund for New York City
, Sofinnova Partners
,
WuXi AppTec
May 14, 2018
Ansun BioPharma
$85.0M Series A
Lilly Asia Ventures
,
Sinopharm Capital
3E Bioventures Capital
,
Joincap Investment
,
LYFE Capital
,
Matrix Partners China
,
VI Ventures
,
YuanMing Capital